Korean J Med Phys.  2009 Sep;20(3):125-131.

A Study of Drug Content and Cell Cytotoxicity of Paclitaxel-eluting Stents Coated with Various Biopolymer

Affiliations
  • 1Institute of Interventional Medicine, M. I. Tech Co., Lnc, Pyeongtaek,Korea.
  • 2Department of Polymer Science and Engineering, Sunchon National University, Suncheon, Korea.
  • 3Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul, Korea. shkim@mitech.co.kr

Abstract

In this study, the paclitaxel eluting stent (PES) was prepared by coating a biliary stent with paclitaxel using various biopolymer such as poly (vinyl acetate) (PVAc), poly (lactic-co-glycolic acid) (PLGA), Silicone rubber for restenosis prevention in gastrointestinal disease by a dip-coating method. Drug contents of PES were increased as surface area of stent, concentration and molecular weight of coating polymer increase. In 1H-NMR specta, we know that drug did not change by confirming specific peaks of paclitaxel in PES. As shown in SEM image, PES prepared using various biopolymer is coated clearly and regularly except Silicone rubber coating polymer. In in vitro cell cytotoxicity test, bare stent showed low cytotoxic effect against CT-26 colon carcinoma cell line on 3 day. However, PES coated with PLGA 502H showed the highest cytotoxicity because PLGA 502H is biodegradable polymer and has less molecular weight than other coating polymer. These results suggest that PES coated various biopolymer can be prevented restenosis in gastrointestinal disease.

Keyword

Drug eluting stent; Paclitaxel; Biopolymer; Restenosis; Drug contents

MeSH Terms

Biopolymers
Cell Line
Colon
Gastrointestinal Diseases
Lactic Acid
Molecular Weight
Paclitaxel
Polyglycolic Acid
Polymers
Silicone Elastomers
Stents
Biopolymers
Lactic Acid
Paclitaxel
Polyglycolic Acid
Polymers
Silicone Elastomers
Full Text Links
  • KJMP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr